{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:45:49Z","timestamp":1785905149834,"version":"3.56.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["Z200014"],"award-info":[{"award-number":["Z200014"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.exer.2026.111134","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:43:11Z","timestamp":1781851391000},"page":"111134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Minocycline as a therapeutic candidate in diabetic retinopathy: insights into pathophysiology and translational potential"],"prefix":"10.1016","volume":"270","author":[{"given":"Chengzhi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4885-4537","authenticated-orcid":false,"given":"Xusheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2026.111134_bib1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exer.2026.111134_bib2","article-title":"Minocycline-induced scleral pigmentation","volume":"26","author":"Al Hussein Al Awamlh","year":"2022","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.exer.2026.111134_bib3","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1073\/pnas.0600554103","article-title":"Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations","volume":"103","author":"Alano","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.exer.2026.111134_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1167\/iovs.61.6.46","article-title":"Metformin corrects abnormal circadian rhythm and Kir4.1 channels in diabetes","volume":"61","author":"Alex","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib5","doi-asserted-by":"crossref","first-page":"e858","DOI":"10.1016\/j.jcjo.2025.04.009","article-title":"Short-term effects of tetracycline use in patients with diabetic retinopathy. Canadian journal of ophthalmology","volume":"60","author":"Alshaikhsalama","year":"2025","journal-title":"J. Can. Ophtalmol."},{"key":"10.1016\/j.exer.2026.111134_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/ijms19010110","article-title":"The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration","author":"Altmann","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11892-014-0573-2","article-title":"From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy","volume":"15","author":"Arboleda-Velasquez","year":"2015","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.exer.2026.111134_bib8","article-title":"Minocycline-induced ocular ochronosis","volume":"15","author":"Baaklini","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.exer.2026.111134_bib9","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s13311-023-01426-9","article-title":"Treating traumatic brain injury with minocycline","volume":"20","author":"Bergold","year":"2023","journal-title":"Neurotherapeutics : J. Am. Soc. Experiment. NeuroTherapeutic."},{"key":"10.1016\/j.exer.2026.111134_bib10","doi-asserted-by":"crossref","first-page":"C772","DOI":"10.1152\/ajpcell.00112.2022","article-title":"Inward rectifier potassium (Kir) channels in the retina: living our vision","volume":"323","author":"Beverley","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2026.111134_bib11","first-page":"181","article-title":"Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats","volume":"2","author":"Bhatt","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.exer.2026.111134_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2009.06.021","article-title":"Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii","volume":"34","author":"Bishburg","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.exer.2026.111134_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00003495-197509040-00005","article-title":"Minocycline: a review of its antibacterial and pharmacokinetic properties and therapeutic use","volume":"9","author":"Brogden","year":"1975","journal-title":"Drugs"},{"key":"10.1016\/j.exer.2026.111134_bib14","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2174\/1567205013666160819124206","article-title":"The anti-inflammatory role of minocycline in Alzheimer's disease","volume":"13","author":"Budni","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.exer.2026.111134_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00011-016-1002-6","article-title":"Activation of the TXNIP\/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline","volume":"66","author":"Chen","year":"2017","journal-title":"Inflamm. Res. : Off. J. Europ. Histamine Res. Soc."},{"key":"10.1016\/j.exer.2026.111134_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13102778","article-title":"Beyond VEGF: angiopoietin-tie signaling pathway in diabetic retinopathy","volume":"13","author":"Chen-Li","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2026.111134_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3949\/ccjm.91a.24028","article-title":"Diabetic retinopathy: screening, prevention, and treatment","volume":"91","author":"Chong","year":"2024","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.exer.2026.111134_bib19","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1167\/iovs.11-9413","article-title":"Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I\/II clinical study","volume":"53","author":"Cukras","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib20","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1167\/iovs.11-9413","article-title":"Oral minocycline for the treatment of Diabetic Macular Edema (DME): results of a phase I\/II clinical study","volume":"53","author":"Cukras","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib21","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.033597","article-title":"Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage","volume":"11","author":"Dannhausen","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.exer.2026.111134_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00210-015-1115-4","article-title":"Organ-protective effects on the liver and kidney by minocycline in small piglets undergoing cardiopulonary bypass","volume":"388","author":"Dhein","year":"2015","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.exer.2026.111134_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1574886316666210120090446","article-title":"Adverse reactions induced by minocycline: a review of literature","volume":"16","author":"Dominic","year":"2021","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.exer.2026.111134_bib24","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.cmet.2024.04.013","article-title":"Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy","volume":"36","author":"Dorweiler","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.exer.2026.111134_bib25","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1001\/jama.2021.17633","article-title":"Management of acne vulgaris: a review","volume":"326","author":"Eichenfield","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.exer.2026.111134_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1592\/phco.26.4.515","article-title":"Minocycline for short-term neuroprotection","volume":"26","author":"Elewa","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.exer.2026.111134_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/15569527.2015.1081604","article-title":"Determination of the toxicity of intravitreal minocycline in rabbit eyes","volume":"35","author":"Falavarjani","year":"2016","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.exer.2026.111134_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pharmthera.2016.11.008","article-title":"Pericytes, an overlooked player in vascular pathobiology","volume":"171","author":"Ferland-McCollough","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.exer.2026.111134_bib29","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.neuroscience.2005.03.019","article-title":"Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions","volume":"133","author":"Fernandez-Gomez","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2026.111134_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2026.111134_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: a dynamic mark in health, disease and inheritance","volume":"13","author":"Greer","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.exer.2026.111134_bib32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/OPX.0000000000001024","article-title":"Minocycline-induced scleral and dermal hyperpigmentation","volume":"94","author":"Haskes","year":"2017","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1538\/expanim.21-0028","article-title":"Minocycline attenuates neuronal apoptosis and improves motor function after traumatic brain injury in rats","volume":"70","author":"He","year":"2021","journal-title":"Exp. Anim."},{"key":"10.1016\/j.exer.2026.111134_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/NHYK3694","article-title":"A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy","volume":"29","author":"Hodgson","year":"2025","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.exer.2026.111134_bib35","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exer.2026.111134_bib36","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1167\/iovs.09-4661","article-title":"Chemotactic and cytotoxic effects of minocycline on human retinal pigment epithelial cells","volume":"51","author":"Hollborn","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10456-024-09911-1","article-title":"Microglia in retinal angiogenesis and diabetic retinopathy","volume":"27","author":"Hu","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.exer.2026.111134_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197413","article-title":"Pericyte-endothelial interactions in the retinal microvasculature","volume":"21","author":"Huang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101349","article-title":"Microglial regulation of the retinal vasculature in health and during the pathology associated with diabetes","volume":"106","author":"Jobling","year":"2025","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2026.111134_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2024.100077","article-title":"Diabetic retinopathy","volume":"13","author":"Jonas","year":"2024","journal-title":"Asia. Pac. J. Ophthalmol. (Phila)"},{"key":"10.1016\/j.exer.2026.111134_bib41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3928\/23258160-20160324-09","article-title":"Swept-source optical coherence tomography and OCT angiography of minocycline-induced retinal and systemic hyperpigmentation","volume":"47","author":"Jung","year":"2016","journal-title":"Ophthalmic Surg. Laser. Imag. Retina"},{"key":"10.1016\/j.exer.2026.111134_bib42","doi-asserted-by":"crossref","first-page":"25869","DOI":"10.1074\/jbc.M112.375204","article-title":"Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC)","volume":"287","author":"Kadiyala","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2026.111134_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nano.2012.03.004","article-title":"Nanoliposomal minocycline for ocular drug delivery","volume":"9","author":"Kaiser","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.exer.2026.111134_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138945013804806442","article-title":"Minocycline mediated mitochondrial cytoprotection: premises for therapy of cerebrovascular and neurodegenerative diseases","volume":"14","author":"Karachitos","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.exer.2026.111134_bib45","first-page":"1683","article-title":"[Minocycline diffusion into prostatic tissue]","volume":"34","author":"Kawashima","year":"1988","journal-title":"Hinyokika Kiyo"},{"key":"10.1016\/j.exer.2026.111134_bib46","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1097\/IOP.0000000000000315","article-title":"Conjunctival pigmentation following minocycline therapy","volume":"32","author":"Khan","year":"2016","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"10.1016\/j.exer.2026.111134_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/iovs.61.10.10","article-title":"Effects of diabetes on mitochondrial morphology and its implications in diabetic retinopathy","volume":"61","author":"Kim","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","article-title":"Minocycline and neurodegenerative diseases","volume":"196","author":"Kim","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.exer.2026.111134_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.184465","article-title":"Immunomodulation of inflammatory responses preserves retinal integrity in murine models of pericyte-depletion retinopathy","volume":"10","author":"Kinuthia","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.exer.2026.111134_bib50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.visres.2017.02.011","article-title":"Diabetic retinopathy, metabolic memory and epigenetic modifications","volume":"139","author":"Kowluru","year":"2017","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2026.111134_bib51","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2337\/diabetes.54.5.1559","article-title":"Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy","volume":"54","author":"Krady","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2026.111134_bib52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.exer.2010.11.007","article-title":"Involvement of oxidative stress and mitochondrial dysfunction in the osmotic swelling of retinal glial cells from diabetic rats","volume":"92","author":"Kr\u00fcgel","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2026.111134_bib53","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2009.06.007","article-title":"Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice","volume":"1286","author":"Kuang","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.exer.2026.111134_bib54","article-title":"Minocycline alleviates lipopolysaccharide-induced cardiotoxicity by suppressing the NLRP3\/Caspase-1 signaling pathway","volume":"14","author":"Li","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2026.111134_bib55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12886-023-03118-6","article-title":"Research progress on the pathogenesis of diabetic retinopathy","volume":"23","author":"Li","year":"2023","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.exer.2026.111134_bib56","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1007\/s12035-015-9318-8","article-title":"Minocycline protects against NLRP3 inflammasome-induced inflammation and P53-Associated apoptosis in early brain injury after subarachnoid hemorrhage","volume":"53","author":"Li","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.exer.2026.111134_bib57","doi-asserted-by":"crossref","DOI":"10.1017\/S0952523821000031","article-title":"Retinal microglia polarization in diabetic retinopathy","volume":"38","author":"Li","year":"2021","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.exer.2026.111134_bib58","first-page":"460","article-title":"Safety evaluation and pharmacodynamics of minocycline hydrochloride eye drops","volume":"28","author":"Li","year":"2022","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2026.111134_bib59","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051803","article-title":"The interplay between DNA and histone methylation: molecular mechanisms and disease implications","volume":"22","author":"Li","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.exer.2026.111134_bib60","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/jdi.13480","article-title":"Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy","volume":"12","author":"Lin","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.exer.2026.111134_bib61","article-title":"Thioredoxin-interacting protein in diabetic retinal neurodegeneration: a novel potential therapeutic target for diabetic retinopathy","volume":"16","author":"Liu","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2026.111134_bib62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/nbu.70015","article-title":"Molecular insights into carotenoid-based interventions for diabetic retinopathy","volume":"50","author":"Liu","year":"2025","journal-title":"Nutr. Bull."},{"key":"10.1016\/j.exer.2026.111134_bib63","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4103\/1673-5374.361536","article-title":"Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surface","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.exer.2026.111134_bib64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2025.10.004","article-title":"DNA methylation and histone modifications drive the trained immunity duration","volume":"47","author":"Liu","year":"2026","journal-title":"Trends Immunol."},{"key":"10.1016\/j.exer.2026.111134_bib65","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/biom15040575","article-title":"Histone modifications: potential therapeutic targets for diabetic retinopathy","volume":"15","author":"Lu","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.exer.2026.111134_bib66","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-161381","article-title":"Minocycline regulates PARP-1 and HDAC3 pathways to inhibit inflammation and oxidative stress in LPS-induced acute lung injury","volume":"24","author":"Luo","year":"2025","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.exer.2026.111134_bib67","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2018.3088","article-title":"Long-term minocycline therapy with scleral pigmentation simulating melanocytosis","volume":"136","author":"Maloney","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.exer.2026.111134_bib68","article-title":"Anti-vascular endothelial growth factor for proliferative diabetic retinopathy","volume":"2014","author":"Martinez-Zapata","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.exer.2026.111134_bib69","series-title":"Antibiotics (Basel, Switzerland","article-title":"A review of systemic minocycline side effects and topical minocycline as a safer alternative for treating acne and rosacea","volume":"10","author":"Martins","year":"2021"},{"key":"10.1016\/j.exer.2026.111134_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9100905","article-title":"Diabetic retinopathy: the role of mitochondria in the neural retina and microvascular disease","volume":"9","author":"Miller","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.exer.2026.111134_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910502","article-title":"Epigenetic mechanisms in type 2 diabetes retinopathy: a systematic review","volume":"22","author":"Milluzzo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib72","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/glia.23007","article-title":"Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor","volume":"64","author":"M\u00f6ller","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.exer.2026.111134_bib73","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2460\/ajvr.71.9.1062","article-title":"Pharmacokinetics and tissue distribution of minocycline hydrochloride in horses","volume":"71","author":"Nagata","year":"2010","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.exer.2026.111134_bib74","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/icb.2014.114","article-title":"Epigenetic modifications of the immune system in health and disease","volume":"93","author":"Obata","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.exer.2026.111134_bib75","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tibs.2021.01.014","article-title":"Rapid detection and signaling of DNA damage by PARP-1","volume":"46","author":"Pandey","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065250","article-title":"Minocycline as treatment for psychiatric and neurological conditions: a systematic review and meta-analysis","volume":"24","author":"Panizzutti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.molcel.2025.12.029","article-title":"Epigenetic consequences of DNA damage","volume":"86","author":"Paull","year":"2026","journal-title":"Mol. Cell"},{"key":"10.1016\/j.exer.2026.111134_bib78","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.exer.2026.111134_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108796","article-title":"Inflammation: the link between neural and vascular impairment in the diabetic retina and therapeutic implications","volume":"24","author":"Ramos","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib80","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1002\/lary.25365","article-title":"Minocycline-induced hyperpigmentation of tympanic membrane, sclera, teeth, and pinna","volume":"125","author":"Reese","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.exer.2026.111134_bib81","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1007\/s00210-023-02839-1","article-title":"Minocycline as a prospective therapeutic agent for cancer and non-cancer diseases: a scoping review","volume":"397","author":"Rezaei","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.exer.2026.111134_bib82","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/ene.14642","article-title":"Minocycline in neurodegenerative and psychiatric diseases: an update","volume":"28","author":"Romero-Miguel","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.exer.2026.111134_bib83","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41398-020-00942-y","article-title":"Neuroinflammatory alterations in trait anxiety: modulatory effects of minocycline","volume":"10","author":"Rooney","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.exer.2026.111134_bib84","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","article-title":"Clinical pharmacokinetics of doxycycline and minocycline","volume":"15","author":"Saivin","year":"1988","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.exer.2026.111134_bib85","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bpa.12242","article-title":"Hippocampal neuroprotection by minocycline and Epigallo-Catechin-3-Gallate against cardiopulmonary bypass-associated injury","volume":"25","author":"Salameh","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.exer.2026.111134_bib87","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1111\/febs.12563","article-title":"Interaction of the antibiotic minocycline with liver mitochondria - role of membrane permeabilization in the impairment of respiration","volume":"280","author":"Sch\u00f6nfeld","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.exer.2026.111134_bib86","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12974-015-0431-4","article-title":"Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration","volume":"12","author":"Scholz","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2026.111134_bib88","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/jamaophthalmol.2014.1422","article-title":"Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial","volume":"132","author":"Scott","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.exer.2026.111134_bib89","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamaophthalmol.2014.93","article-title":"Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or Non\u2013high-risk proliferative diabetic retinopathy: a randomized clinical trial","volume":"132","author":"Scott","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.exer.2026.111134_bib90","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s12011-022-03305-4","article-title":"Minocycline protects PC12 cells against cadmium-induced neurotoxicity by modulating apoptosis","volume":"201","author":"Shayan","year":"2023","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.exer.2026.111134_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112703","article-title":"Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis","volume":"139","author":"Shi","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.exer.2026.111134_bib92","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/APO.0000000000000510","article-title":"Diabetic retinopathy: role of neurodegeneration and therapeutic perspectives","volume":"11","author":"Sim\u00f3","year":"2022","journal-title":"Asia-Pac. J. Ophthalmol. (Philadelphia, Pa.)"},{"key":"10.1016\/j.exer.2026.111134_bib93","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1007\/s00125-018-4692-1","article-title":"Neurodegeneration in diabetic retinopathy: does it really matter?","volume":"61","author":"Sim\u00f3","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2026.111134_bib94","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.survophthal.2024.07.001","article-title":"Diabetic retinopathy: new concepts of screening, monitoring, and interventions","volume":"69","author":"Sinclair","year":"2024","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111134_bib95","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2174\/1874467214666210210122628","article-title":"Minocycline and doxycycline: more than antibiotics","volume":"14","author":"Singh","year":"2021","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.exer.2026.111134_bib96","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10495-011-0590-4","article-title":"Minocycline suppresses oxidative stress and attenuates fetal cardiac myocyte apoptosis triggered by in utero cocaine exposure. Apoptosis","volume":"16","author":"Sinha-Hikim","year":"2011","journal-title":"Int. J. Programm. Cell Death"},{"key":"10.1016\/j.exer.2026.111134_bib97","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41572-025-00646-x","article-title":"Diabetic retinal disease","volume":"11","author":"Sivaprasad","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.exer.2026.111134_bib98","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.adaj.2015.01.028","article-title":"Systematic review and meta-analysis on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts","volume":"146","author":"Smiley","year":"2015","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.exer.2026.111134_bib99","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/1389203719666180914093109","article-title":"Targeting matrix metalloproteinases for diabetic retinopathy: the way ahead?","volume":"20","author":"Solanki","year":"2019","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1073858405275175","article-title":"Minocycline as a neuroprotective agent","volume":"11","author":"Stirling","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1016\/j.exer.2026.111134_bib101","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10072-014-1647-2","article-title":"Minocycline improves peripheral and autonomic neuropathy in type 2 diabetes: MIND study","volume":"35","author":"Syngle","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib102","article-title":"Diabetic retinopathy: looking forward to 2030","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2026.111134_bib103","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3892\/ijmm.2017.2908","article-title":"Minocycline attenuates sevoflurane-induced cell injury via activation of Nrf2","volume":"39","author":"Tian","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.exer.2026.111134_bib104","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1167\/iovs.16-21355","article-title":"High glucose induces mitochondrial dysfunction in retinal m\u00fcller cells: implications for diabetic retinopathy","volume":"58","author":"Tien","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111134_bib105","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2337\/db06-0427","article-title":"Inhibition of caspase-1\/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia","volume":"56","author":"Vincent","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2026.111134_bib106","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuint.2005.04.018","article-title":"Minocycline inhibits LPS-induced retinal microglia activation","volume":"47","author":"Wang","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.exer.2026.111134_bib107","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/glia.22405","article-title":"Elevated histone acetylations in M\u00fcller cells contribute to inflammation: a novel inhibitory effect of minocycline","volume":"60","author":"Wang","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.exer.2026.111134_bib108","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2014.12.021","article-title":"Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"287","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2026.111134_bib109","article-title":"Abnormal levels of histone methylation in the retinas of diabetic rats are reversed by minocycline treatment","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2026.111134_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152829","article-title":"Diabetic retinopathy from the perspective of programmed cell death: focusing on apoptosis, pyroptosis, and necroptosis","volume":"788","author":"Wang","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2026.111134_bib111","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.3892\/mmr.2015.4064","article-title":"Minocycline inhibits PARP-1 expression and decreases apoptosis in diabetic retinopathy","volume":"12","author":"Wu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.exer.2026.111134_bib112","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/14740338.2024.2392865","article-title":"Systematic analysis of the adverse effects of commonly used clinical tetracycline drugs based on the FAERS database","volume":"24","author":"Xiong","year":"2025","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.exer.2026.111134_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107887","article-title":"Minocycline induces apoptosis of photoreceptor cells by regulating ER stress","volume":"190","author":"Xu","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2026.111134_bib114","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jemt.24258","article-title":"Elevated retinal retinol-binding protein 4 levels in diabetic mice can induce retinal neurodegeneration through microglia","volume":"86","author":"Xu","year":"2023","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.exer.2026.111134_bib115","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1093\/nar\/gkab415","article-title":"Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response","volume":"49","author":"Yu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.exer.2026.111134_bib116","article-title":"Minocycline-induced retinal pigment epithelium hyperpigmentation masquerading as age-related macular degeneration: case presentation and proposed mechanism","volume":"36","author":"Yu","year":"2024","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.exer.2026.111134_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1055087","article-title":"The role of inflammation in immune system of diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications","volume":"13","author":"Yue","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2026.111134_bib118","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/147323001103900214","article-title":"Expression of aquaporin 4 and Kir4.1 in diabetic rat retina: treatment with minocycline","volume":"39","author":"Zhang","year":"2011","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.exer.2026.111134_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175903","article-title":"The mechanisms of minocycline in alleviating ischemic stroke damage and cerebral ischemia-reperfusion injury","volume":"955","author":"Zhao","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2026.111134_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13070796","article-title":"Cancer metabolism: the role of ROS in DNA damage and induction of apoptosis in cancer cells","volume":"13","author":"Zhao","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.exer.2026.111134_bib121","article-title":"Retinal cell damage in diabetic retinopathy","author":"Zhou","year":"2023","journal-title":"Cells 12"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:58:45Z","timestamp":1785902325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526002903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":121,"alternative-id":["S0014483526002903"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.111134","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minocycline as a therapeutic candidate in diabetic retinopathy: insights into pathophysiology and translational potential","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.111134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111134"}}